HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coal tar/menthol dandruff shampoo to be proposed as Category I combination -- FDA.

This article was originally published in The Rose Sheet

Executive Summary

COAL TAR/MENTHOL DANDRUFF INGREDIENT COMBO TO BE DEEMED CATEGORY I (safe and effective for OTC use) in an upcoming Federal Register notice, FDA told Denorex manufacturer Whitehall-Robins in a Jan. 17 letter. Based on data submitted by Whitehall in a March 1993 citizen petition, FDA plans to amend the 1991 final monograph for OTC dandruff, seborrheic dermatitis and psoriasis drug products to include 1.8% coal tar/1.5% menthol as a Category I combination for control and relief of dandruff symptoms. A brief comment period will follow publication of the proposal; formal ruling on the petition occurs with the publication of a final rule.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003723

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel